Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding systemic sclerosis through gene expression profiling.

Sarah A Pendergrass1, Michael L Whitfield, Humphrey Gardner

  • 1Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire, USA.

Current Opinion in Rheumatology
|October 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WNT5A induces profibrotic activation of human macrophages via pSTAT3.

Rheumatology (Oxford, England)·2026
Same author

Insights Into Systemic Sclerosis from Gene Expression Profiling.

Current treatment options in rheumatology·2026
Same author

Multimodal analyses of early, untreated systemic sclerosis skin identify a proinflammatory vascular niche of macrophage-fibroblast signaling.

JCI insight·2025
Same author

RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis.

Annals of the rheumatic diseases·2025
Same author

Anti-CD206 CAR T Cell Treatment Restores Fibrosis-Induced Loss of Dermal White Adipose Tissue.

bioRxiv : the preprint server for biology·2025
Same author

Phase 1/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor-relapsed tumors.

Investigational new drugs·2025
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Gene expression profiling in systemic sclerosis (SSc) reveals early disease changes and identifies patient subgroups. This technique offers valuable prognostic insights for SSc, advancing disease understanding and treatment strategies.

Area of Science:

  • Genomics
  • Molecular Biology
  • Immunology

Background:

  • Genomic analysis is increasingly vital for understanding complex diseases like systemic sclerosis (SSc).
  • Gene expression profiling in SSc has shown promise for diagnosis, prognosis, and understanding disease mechanisms.

Purpose of the Study:

  • To review the current applications and future potential of gene expression profiling in systemic sclerosis.
  • To highlight the diagnostic, prognostic, and pathogenetic insights gained from gene profiling studies in SSc.

Main Methods:

  • Analysis of gene expression profiles from skin biopsies of SSc patients.
  • Evaluation of gene expression data from animal models and explanted fibroblasts of SSc.
  • Review of recent advancements in sample collection and standardization for gene profiling.

Related Experiment Videos

Main Results:

  • Significant gene expression changes in SSc skin biopsies precede clinical manifestations.
  • Gene profiling can identify distinct SSc subgroups with varying pathogenesis and outcomes.
  • Studies using animal models and fibroblasts reveal their utility and limitations in SSc research.

Conclusions:

  • Gene profiling is expected to yield crucial prognostic information for systemic sclerosis patients.
  • Advances in methodology facilitate longitudinal sample collection for enhanced SSc research.
  • Standardized gene profiling will significantly advance the understanding of systemic sclerosis pathogenesis and patient stratification.